> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Contracts with AnaBios for Cardiac Function Research
- URL: https://www.fdaweb.com/fda-contracts-with-anabios-for-cardiac-function-research/
- Published: 2019-11-05T12:00:00.000Z
- Updated: 2026-09-14T15:51:53.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5145420

FDA has awarded AnaBios an “Indefinite Delivery, Indefinite Quantity” contract to access its adult human primary tissues and cardiomyocytes from organ donors to assess drug safety related to cardiac function. The company says it has worked for a decade to develop a translational *ex-vivo* human heart platform. “We anticipate this collaboration will deliver critical data that could improve future regulatory and pharmaceutical industry decision-making,” it says. The contract provides FDA access to AnaBios’ “Electrophysiological and Contractility Assessment of Drugs on Primary Adult Ventricular Tissues” research for adverse events evaluations.